儿童与青少年肾上腺功能不全的诊治策略
本文围绕儿童与青少年肾上腺功能不全(AI)的治疗目标展开,包括预防危及生命的肾上腺危象、优化线性生长、在先天性肾上腺增生症(CAH)患者中控制雄激素水平而不致过量,以及改善生活质量。文章指出标准糖皮质激素制剂无法复现皮质醇昼夜节律,也无法控制促肾上腺皮质激素驱动的肾上腺雄激素生成,并综述了更贴近生理性皮质醇分泌的新型给药策略与辅助治疗,还介绍了3例不同病因与就诊时机的AI病例。
要点
- 治疗目标包括预防肾上腺危象、优化线性生长、在CAH中控制雄激素而不过量、改善生活质量。
- 标准糖皮质激素制剂无法复现皮质醇昼夜节律,也不能控制促肾上腺皮质激素驱动的肾上腺雄激素生成。
- 已开发更贴近生理性皮质醇分泌的新型给药策略与辅助治疗,以个体化调整糖皮质激素治疗。
核心结论
- 标准糖皮质激素制剂无法复现皮质醇昼夜节律,也无法控制促肾上腺皮质激素驱动的肾上腺雄激素生成,因此需要更贴近生理性皮质醇分泌的新型策略来个体化治疗并改善结局。
研究设计与样本
- 本文为综述,包含3例不同病因与就诊时机的肾上腺功能不全(AI)病例,并汇总儿童与青少年AI个体化治疗的最新证据。
主要发现
- 本文呈现3例不同病因与就诊时机的AI病例,讨论其诊断与处理过程,重点在治疗与结局。
- 新型治疗策略包括新的昼夜皮质醇替代给药方式,以及减少雄激素生成和/或雄激素作用/效应的多种辅助治疗。
- 临床前研究正在探索修复性细胞治疗的作用,首个基于重组腺相关病毒的基因治疗也正在CAH患者中开发。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The management of adrenal insufficiency (AI) is challenging, and the overall goals of treatment are to prevent life-threatening adrenal crises, to optimize linear growth, to control androgen levels without overdosing in patients with congenital adrenal hyperplasia (CAH), and to improve quality of life in affected individuals. Standard glucocorticoid formulations fail to replicate the circadian rhythm of cortisol and control the adrenal androgen production driven by adrenocorticotropin. To personalize and tailor glucocorticoid therapy and to improve patient outcomes, new pharmacological strategies have been developed that best mimic physiological cortisol secretion. Novel therapeutic approaches in the management of AI include new ways to deliver circadian cortisol replacement as well as various adjunctive therapies to reduce androgen production and/or androgen action/effects. Preclinical studies are exploring the role of restorative cell-based therapies, and a first recombinant adeno-associated virus-based gene therapy is also being developed in humans with CAH. In this article, we present 3 illustrative cases of AI with different underlying etiologies and times of presentation. Diagnostic and management processes are discussed with an emphasis on treatment and outcomes. We have also provided the most up-to-date evidence for the tailored management of children and adolescents with AI.
引用
- Patti G, Zucconi A, Matarese S, et al. Approach to the Child and Adolescent With Adrenal Insufficiency. J Clin Endocrinol Metab. 2025. PMID: 39155058. doi:10.1210/clinem/dgae564
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。